Newer genetic tests introduce more ambiguity, but a new study finds patients are not overreacting to uncertain results.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
A genomic duplication may help explain why esophageal adenocarcinoma is much more common in Caucasians and presents a potential target for prevention.
As residency programs struggle to balance the well-being of trainees and the need to provide ample training, a new study finds inconsistent parental leave policies.
A study of colonoscopy recipients finds mixed feelings about using age, life expectancy and risk calculators to guide screening. How doctors can steer the conversation.
More funding, scientific insights and clinical advances have started to drive progress in this challenging disease, and researchers see potential for immunotherapy to revolutionize its future.
Patients feel providers do not adequately address concerns about the cost of cancer treatment, which can heighten anxiety during an already stressful time.